IMMUNO-BIOLOGICAL LABORATORIES CO financial statements, including revenue, expenses, profit, and loss
The total revenue of 4570 for the last quarter is 214.52 M JPY, and it's 6.57% lower compared to the previous quarter. The net income of Q2 24 is 20.16 M JPY.